896466-04-9
1-cyclopropyl-3-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]urea
Molecular Identity
896466-04-9
1-cyclopropyl-3-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]urea
PubChem CID: 135398495
1-cyclopropyl-3-[3-[5-(4-morpholinylmethyl)-2-benzimidazolylidene]-1,2-dihydropyrazol-4-yl]urea is a member of benzimidazoles.
2D Structure
Properties
C19H23N7O2
Molecular Formula
381.40
Molecular Weight
g/mol
381.1913
Exact Mass
Da
0.5
XLogP
Drug-like (Lipinski: < 5)
111
TPSA
Good oral absorption (< 140 A²)
4
H-Bond Donors
5
H-Bond Acceptors
554
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
896466-04-9AT9283AT-9283AT 9283XAV9KYN9WLAT 9283 [WHO-DD]Urea, N-cyclopropyl-N'-(3-(6-(4-morpholinylmethyl)-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl)-1-cyclopropyl-3-[(3Z)-3-[5-(morpholin-4-ylmethyl)benzimidazol-2-ylidene]-1,2-dihydropyrazol-4-yl]urea1-cyclopropyl-3-((3Z)-3-(5-(morpholin-4-ylmethyl)benzimidazol-2-ylidene)-1,2-dihydropyrazol-4-yl)ureaRefChem:560290Multikinase Inhibitor AT9283Aurora kinase inhibitor AT92831133385-83-71-Cyclopropyl-3-(3-(5-(morpholinomethyl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazol-4-yl)ureaAT-9283 free base
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to 896466-04-9
Loading drug network...